Cochrane Abstracts
Chemotherapy for hormone‐refractory prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chemotherapy for Hormone‐refractory Prostate Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432842/all/Chemotherapy_for_hormone‐refractory_prostate_cancer_Edited__no_change_to_conclusions_. Accessed 30 September 2023.
Chemotherapy for hormone‐refractory prostate cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432842/all/Chemotherapy_for_hormone‐refractory_prostate_cancer_Edited__no_change_to_conclusions_. Accessed September 30, 2023.
Chemotherapy for hormone‐refractory prostate cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432842/all/Chemotherapy_for_hormone‐refractory_prostate_cancer_Edited__no_change_to_conclusions_
Chemotherapy for Hormone‐refractory Prostate Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 September 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432842/all/Chemotherapy_for_hormone‐refractory_prostate_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chemotherapy for hormone‐refractory prostate cancer
ID - 432842
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432842/all/Chemotherapy_for_hormone‐refractory_prostate_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
